| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000028469 |
| Receipt No. | R000032591 |
| Scientific Title | clinical study of Robot-Assisted Radical Cystectomy for invasive bladder cancer |
| Date of disclosure of the study information | 2017/08/01 |
| Last modified on | 2019/08/14 (Ver. 4) |
| Basic information | ||
| Public title | clinical study of Robot-Assisted Radical Cystectomy for invasive bladder cancer | |
| Acronym | RARC for bladder cancer | |
| Scientific Title | clinical study of Robot-Assisted Radical Cystectomy for invasive bladder cancer | |
| Scientific Title:Acronym | RARC for bladder cancer | |
| Region |
|
|
| Condition | ||
| Condition | invasive bladder cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Consider the safety and efficacy for robot-assisted radical cystectomy using daVinci Si System. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Intra and and postoperative complications and their contents |
| Key secondary outcomes | operation time, duration for anesthesia, a, bleeding, postoperative use for pain medication, postoperative hospitalization period, histopathological findings |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Radical cystectomy performed with daVinci Si system,
|
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Invasive bladder cancer cT1-2N0M0
,who obtained written informed consent |
|||
| Key exclusion criteria | 1 The patient seems to be difficult for robot-assisted surgery due to previous surgery.
2. The patient with multiple cancers (cancer combined cancer and disease-free period within five years of different multiple cancer). 3. patients with impossible discontinuation of anticoagulants. 4. patients requiring blood transfusion due to anemia or bleeding. 5. morbid obesity (bimi35 or higher) 6. renal transplant history. 7. dialysis patients. 8. pregnant women or pregnant or lactating women 9. patients with a mental illness or psychiatric symptoms. 10. patients who is difficult for surgical treatment because of serious complications (angina pectoris, myocardial infarction, serious arrhythmias, uncontrolled diabetes, malignant hypertension, etc. 11. patients who have renal dysfunction (serum creatinine levels 1.5mg/dl or more), liver dysfunction (AST, ALT 100IU/l or more). 12. patients with bacterial infections requiring treatments. 13. patients with interstitial pneumonitis and pulmonary fibrosis. 14. patients with severe drug hypersensitivity, drug allergies. 15. minors 16. patients seemed unfit for other reasons. |
|||
| Target sample size | 3 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Jichi Medical University, Satiama Medical Center | ||||||
| Division name | Department of Urology | ||||||
| Zip code | 330-8503 | ||||||
| Address | 1-847 Amanuma-cho, Omiya-ku, Saitama city, Saitama, Japan | ||||||
| TEL | 048-647-2111 | ||||||
| sh2-miya@jichi.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Jichi Medical University, Satiama Medical Center | ||||||
| Division name | Department of Urology | ||||||
| Zip code | 3308503 | ||||||
| Address | 1-847 Amanuma-cho, Omiya-ku, Saitama city, Saitama, Japan | ||||||
| TEL | 048-647-2111 | ||||||
| Homepage URL | |||||||
| sh2-miya@jichi.ac.jp | |||||||
| Sponsor | |
| Institute | Jichi Medical University, Satiama Medical Center
Department of Urology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Jichi Medical University, Satiama Medical Center
Department of Urology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Jichi Medical University, Satiama Medical Center |
| Address | 1-847 Amanuma-cho, Omiya-ku, Saitama city, Saitama, Japan |
| Tel | 048-647-2111 |
| sh2-miya@jichi.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | 3 | ||||||
| Results | All three patients were male Age 64-77 Invasive bladder cancer Urinary diversion is 2 cases of ileal conduit, 1 case of cutaneostomy Surgery time 363-507 minutes Console time 215-267 minutes Blood loss 60-500ml No postoperative complications Discharged 10-14 days after surgery. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000032591 |